Pepbloc FG

Formulation : H-Gly-Pro-Arg-Pro-OH; AcOH

MW(Da) : 485.5 Pepbloc FG binds to fibrinogen to inhibit polymerization of the fibrin network, thereby disrupting the mechanical properties of the clot. Inhibits fibrin formation and turbidity of the fibrin network.

Reference PresentationPackaging  
6-INH-FG-5Vial5 mg

The Safety Data Sheets and Notices are accessible to our registered customers.